Nonsteroidal anti-inflammatory drug (NSAID) prescribing after gastrojejunostomy: A preventable cause of morbidity
Marginal ulcer after gastrojejunostomy is associated with nonsteroidal anti-inflammatory drug prescriptions in a dose-dependent manner. Although acid-suppressing therapy appears protective for marginal ulcer, quality improvement efforts should focus on diminishing nonsteroidal anti-inflammatory drug prescribing in this population.
Authors
- Toms Augustin (ORCID: https://orcid.org/0000-0001-6063-9859)
- Chase J. Wehrle (ORCID: https://orcid.org/0000-0002-9275-4744)
- Ali Aminian (ORCID: https://orcid.org/0000-0001-5756-9917)
- Abby Gross (ORCID: https://orcid.org/0000-0002-5497-5634)
- Kelly Nimylowycz
- Corey K. Gentle (ORCID: https://orcid.org/0000-0003-1001-4185)
- Sayf Said Al-Deen
Institutions
- Twitter (United States) (US)
- Cleveland Clinic (US)
Publication Details
- Journal
- Surgery
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1016/j.surg.2024.07.061
- Citations
- 3
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39